BIRC5 and cancer: The relevance of survivin as an anti-cancer target for OCs has been shown through a meta-analysis in which survivin expression was positively correlated with the International Federation of Gynecology and Obstetrics classifications for staging OCs and could potentially become a novel clinicopathological marker of this cancer type (58).